Ingrown Toenails During Chemotherapy and Stem Cell Transplantation in Children With Hematologic Malignancies and Solid Tumors

Journal of Pediatric Hematology/oncology
Daiki HoriKunihiko Kobayashi

Abstract

At our institution, we noted that children with hematologic malignancies and solid tumors often suffered from ingrown toenails (IGTNs) during hospitalization for chemotherapy and stem cell transplantation. However, only few reports have dealt with IGTNs in the above setting. Between August 2007 and July 2017, 180 children who received treatment for hematologic malignancies and solid tumors at our institute were enrolled in this study. Twelve patients with insufficient data and 7 patients with past histories of IGTNs were excluded. A total of 161 patients were analyzed. Median age at admission was 7.9 years (range, 1.0 to 25.4 y), with 92 males and 69 females. Diagnoses were hematologic diseases in 128 patients, including acute lymphoblastic leukemia (ALL) in 75 patients, and solid tumors in 33 patients. A total of 22 patients (13.7%) suffered from IGTNs (or toe paronychia) during hospitalization. Multivariable analysis disclosed a strong correlation between the occurrence of IGTNs and older age (over 9.0 y) and ALL. Patient-related factors, such as age over 9 years and ALL were associated with IGTNs. This is the first report of a survey on IGTNs in patients with hematologic malignancies and solid tumors hospitalized for chemoth...Continue Reading

References

Jan 1, 1989·The British Journal of Surgery·D T LangfordK Robertson
Nov 1, 1987·The Journal of Bone and Joint Surgery. British Volume·H J PearsonD F Watkin
Jun 27, 1998·Lancet·R ZerboniG Carminati
May 9, 2012·Indian Journal of Dermatology, Venereology and Leprology·Niti Khunger, Rajat Kandhari

❮ Previous
Next ❯

Software Mentioned

R
EZR

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The Medical Journal of Australia
G C Spence
Australian Family Physician
L C Foley
The Medical Journal of Australia
P R Scott
Australian Family Physician
D G Chambers
Canadian Family Physician Médecin De Famille Canadien
R Braun
© 2022 Meta ULC. All rights reserved